Gould Robert J

CIK 00015770342 companiesCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001577034

Recent Transactions

50 trades

Sale
Fulcrum Therapeutics, Inc.$FULC
Common Stock
2022-06-06$8.10/sh−24,382→ 506,630 total
Exercise/Conversion
Fulcrum Therapeutics, Inc.$FULC
Stock Option (right to buy)
2022-06-06−24,382→ 157,958 total
Exercise/Conversion
Fulcrum Therapeutics, Inc.$FULC
Stock Option (right to buy)
2022-06-06−24,382→ 157,958 total
Exercise/Conversion
Fulcrum Therapeutics, Inc.$FULC
Stock Option (right to buy)
2022-06-06−24,382→ 157,958 total
Sale
Fulcrum Therapeutics, Inc.$FULC
Common Stock
2022-06-06$8.10/sh−24,382→ 506,630 total
Exercise/Conversion
Fulcrum Therapeutics, Inc.$FULC
Common Stock
2022-06-06$7.84/sh+24,382→ 531,012 total
Exercise/Conversion
Fulcrum Therapeutics, Inc.$FULC
Common Stock
2022-06-06$7.84/sh+24,382→ 531,012 total
Exercise/Conversion
Fulcrum Therapeutics, Inc.$FULC
Stock Option (right to buy)
2022-06-06−24,382→ 157,958 total
Sale
Fulcrum Therapeutics, Inc.$FULC
Common Stock
2022-06-06$8.10/sh−24,382→ 506,630 total
Exercise/Conversion
Fulcrum Therapeutics, Inc.$FULC
Common Stock
2022-06-06$7.84/sh+24,382→ 531,012 total
Sale
Fulcrum Therapeutics, Inc.$FULC
Common Stock
2022-06-06$8.10/sh−24,382→ 506,630 total
Exercise/Conversion
Fulcrum Therapeutics, Inc.$FULC
Common Stock
2022-06-06$7.84/sh+24,382→ 531,012 total
Sale
Fulcrum Therapeutics, Inc.$FULC
Common Stock
2022-06-03$7.95/sh−25,551→ 506,630 total
Exercise/Conversion
Fulcrum Therapeutics, Inc.$FULC
Common Stock
2022-06-03$7.84/sh+25,551→ 532,181 total
Exercise/Conversion
Fulcrum Therapeutics, Inc.$FULC
Stock Option (right to buy)
2022-06-03−25,551→ 182,340 total
Sale
Fulcrum Therapeutics, Inc.$FULC
Common Stock
2022-06-03$7.95/sh−25,551→ 506,630 total
Sale
Fulcrum Therapeutics, Inc.$FULC
Common Stock
2022-06-03$7.95/sh−25,551→ 506,630 total
Exercise/Conversion
Fulcrum Therapeutics, Inc.$FULC
Common Stock
2022-06-03$7.84/sh+25,551→ 532,181 total
Exercise/Conversion
Fulcrum Therapeutics, Inc.$FULC
Stock Option (right to buy)
2022-06-03−25,551→ 182,340 total
Exercise/Conversion
Fulcrum Therapeutics, Inc.$FULC
Common Stock
2022-06-03$7.84/sh+25,551→ 532,181 total
Exercise/Conversion
Fulcrum Therapeutics, Inc.$FULC
Stock Option (right to buy)
2022-06-03−25,551→ 182,340 total
Sale
Fulcrum Therapeutics, Inc.$FULC
Common Stock
2022-06-03$7.95/sh−25,551→ 506,630 total
Exercise/Conversion
Fulcrum Therapeutics, Inc.$FULC
Stock Option (right to buy)
2022-06-03−25,551→ 182,340 total
Exercise/Conversion
Fulcrum Therapeutics, Inc.$FULC
Common Stock
2022-06-03$7.84/sh+25,551→ 532,181 total
Sale
Fulcrum Therapeutics, Inc.$FULC
Common Stock
2022-06-02$7.92/sh−16,689→ 506,630 total
Exercise/Conversion
Fulcrum Therapeutics, Inc.$FULC
Common Stock
2022-06-02$7.84/sh+16,689→ 523,319 total
Sale
Fulcrum Therapeutics, Inc.$FULC
Common Stock
2022-06-02$7.92/sh−16,689→ 506,630 total
Exercise/Conversion
Fulcrum Therapeutics, Inc.$FULC
Stock Option (right to buy)
2022-06-02−16,689→ 207,891 total
Exercise/Conversion
Fulcrum Therapeutics, Inc.$FULC
Common Stock
2022-06-02$7.84/sh+16,689→ 523,319 total
Exercise/Conversion
Fulcrum Therapeutics, Inc.$FULC
Stock Option (right to buy)
2022-06-02−16,689→ 207,891 total
Sale
Fulcrum Therapeutics, Inc.$FULC
Common Stock
2022-06-02$7.92/sh−16,689→ 506,630 total
Sale
Fulcrum Therapeutics, Inc.$FULC
Common Stock
2022-06-02$7.92/sh−16,689→ 506,630 total
Exercise/Conversion
Fulcrum Therapeutics, Inc.$FULC
Stock Option (right to buy)
2022-06-02−16,689→ 207,891 total
Exercise/Conversion
Fulcrum Therapeutics, Inc.$FULC
Common Stock
2022-06-02$7.84/sh+16,689→ 523,319 total
Exercise/Conversion
Fulcrum Therapeutics, Inc.$FULC
Common Stock
2022-06-02$7.84/sh+16,689→ 523,319 total
Exercise/Conversion
Fulcrum Therapeutics, Inc.$FULC
Stock Option (right to buy)
2022-06-02−16,689→ 207,891 total
Award
Fulcrum Therapeutics, Inc.$FULC
Stock Option (right to buy)
2020-01-23+200,000→ 200,000 total
Award
Fulcrum Therapeutics, Inc.$FULC
Stock Option (right to buy)
2020-01-23+200,000→ 200,000 total
Exercise/Conversion
Epizyme, Inc.
Common Stock, par value $0.0001 per share
2014-01-02$0.51/sh+3,334→ 3,334 total
Exercise/Conversion
Epizyme, Inc.
Stock Option (Right to Buy)
2014-01-02−3,334→ 867,223 total
Exercise/Conversion
Epizyme, Inc.
Common Stock, par value $0.0001 per share
2014-01-02$0.33/sh+14,131→ 14,131 total
Sale
Epizyme, Inc.
Common Stock, par value $0.0001 per share
2014-01-02$20.16/sh−14,131→ 0 total
Sale
Epizyme, Inc.
Common Stock, par value $0.0001 per share
2014-01-02$20.16/sh−12,535→ 0 total
Sale
Epizyme, Inc.
Common Stock, par value $0.0001 per share
2014-01-02$20.16/sh−12,535→ 0 total
Exercise/Conversion
Epizyme, Inc.
Common Stock, par value $0.0001 per share
2014-01-02$0.30/sh+12,535→ 12,535 total
Exercise/Conversion
Epizyme, Inc.
Stock Option (Right to Buy)
2014-01-02−3,334→ 867,223 total
Exercise/Conversion
Epizyme, Inc.
Stock Option (Right to Buy)
2014-01-02−14,131→ 0 total
Exercise/Conversion
Epizyme, Inc.
Common Stock, par value $0.0001 per share
2014-01-02$0.33/sh+14,131→ 14,131 total
Sale
Epizyme, Inc.
Common Stock, par value $0.0001 per share
2014-01-02$20.18/sh−3,334→ 0 total
Exercise/Conversion
Epizyme, Inc.
Common Stock, par value $0.0001 per share
2014-01-02$0.30/sh+12,535→ 12,535 total

Companies

Recent Filings

4
Gould Robert J
Jun 6, 2022

Address

C/O FULCRUM THERAPEUTICS, INC. 26 LANDSDOWNE STREET

CAMBRIDGE, MA, 02139

View on SEC.gov